Alto Neuroscience, Inc.
ANRO
Revenue
0.00
0.000.00%
-Assets
197.36M
▼-12.56M▼-5.98%
3 Months ChangeLiabilities
17.58M
▲766.00k▲4.55%
3 Months ChangeFree Cash Flow
-11.21M
▼-3.66M▼-48.54%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-22
Form 8-K
ID: 0001193125-24-241092
2024-08-13
Form 10-Q
ID: 0001999480-24-000035
2024-08-13
Form 8-K
ID: 0001999480-24-000033
2024-07-29
Form 8-K
ID: 0001999480-24-000025
2024-05-21
Form 8-K
ID: 0001193125-24-143369
2024-05-14
Form 10-Q
ID: 0001999480-24-000022
2024-05-14
Form 8-K
ID: 0001999480-24-000020
2024-03-21
Form 8-K
ID: 0001999480-24-000008
2024-03-11
Form 8-K
ID: 0001193125-24-064372
2024-02-06
Form 8-K
ID: 0001193125-24-025266